Planned sale

Stryker Corporation (SYK): Director filed to sell ~$187M

STRYKER RONDA E, Director at Stryker Corporation, filed to sell ~$187M of Stryker Corporation shares.

~$187M
planned to sell · 550K shares, around Nov 6, 2026
Planned for
Nov 6, 2026
Notice filed
Nov 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 15, 2026Federal contract · $2.6M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $2.58M obligated to date
  2. Sep 16, 2026FDARecall: TS Universal Baseplate Finishing Tray, Triathlon. Catalog Number: 6543-6-506.
  3. Sep 16, 2026FDARecall: Triathlon Hinge Femoral Prep Tray. Catalog Number: 6543-6-514.
  4. Sep 16, 2026FDARecall: TS Femoral Prep Tray, Triathlon. Catalog Number: 6543-6-507.
  5. Sep 16, 2026FDARecall: TS Misc. Instruments Tray, Triathlon. Catalog Number: 6543-6-519.
  6. Sep 16, 2026Federal contract · $1.7M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.73M obligated to date
  7. Sep 17, 2026FDAFDA device clearance: Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Square Coated, 70mm Blade, Push Button Switch (0703-046-100);Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Sq…
  8. Sep 24, 2026FDARecall: Precision Pointer Electromagnetic (8000-050-001)
  9. Sep 30, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
  10. Oct 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Stryker Corporation (the “Company”) announced on October 6, 2026 that Kevin A. Lobo will resign from his role as Chief Executive Officer (“CEO”) of the Company on December 31, 2026 and transition to the role of Executive Chair of the Board of Directors of the Company (the “Board”), effective January 1, 2027 (the “CEO Transition”) and that Spencer S. Stiles, who currently serves as President and Chief Operating…”
  11. Oct 8, 2026FDAFDA device clearance: Sonopet iQ Series III Console (5700-050-000); Sonopet iQ+ Straight Handpiece (5500-260-000); Sonopet iQ+ 10mm iQ+ Blade (5500-26B-010); Sonopet iQ+ 20mm iQ+ Bl…
  12. Oct 9, 2026FDAFDA device clearance: Excelsior Reach Microcatheter
  13. Oct 20, 2026FDAFDA device clearance: SafeAir Electrosurgical Generator with Smoke Evacuation (0795-001-000);SafeAir Generator 3-Pedal Footswitch (0795-007-000)
  14. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  15. Nov 6, 2026Insider · 1 personInsiders: 6 sales (~$178.9M)

What came next

  1. Nov 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On November 3, 2026, the Board of Directors of Stryker Corporation (the “Company”) increased the number of authorized directors from 11 to 12 and elected James E. Davis to fill the resulting vacancy.”
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 34 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

How this filing works

Explore the data

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data